OPKO Health Inc (OPK)

10.87
0.32 2.86
NASDAQ : Health Care
Prev Close 11.19
Open 11.17
Day Low/High 10.83 / 11.18
52 Wk Low/High 7.12 / 17.51
Volume 3.81M
Avg Volume 2.96M
Exchange NASDAQ
Shares Outstanding 550.38M
Market Cap 6.09B
EPS -0.10
P/E Ratio 38.14
Div & Yield N.A. (N.A)

Latest News

Look for Test of Key Index Again

Besides testing the S&P 500's 2100 level, we're also likely to see volume pick up as we head toward Friday's triple-witching expiration finale.

OPKO Health Appoints Jane Pine Wood As Chief Legal And Compliance Officer Of BioReference Laboratories

OPKO Health Appoints Jane Pine Wood As Chief Legal And Compliance Officer Of BioReference Laboratories

OPKO Health, Inc. (Nasdaq: OPK) announces the appointment of Jane Pine Wood, Esq.

OPKO To Present Long-acting Human Growth Hormone (hGH-CTP) Phase 2 Pediatric Growth Hormone Deficiency Data At The 55th Annual Meeting Of The European Society For Paediatric Endocrinology

OPKO To Present Long-acting Human Growth Hormone (hGH-CTP) Phase 2 Pediatric Growth Hormone Deficiency Data At The 55th Annual Meeting Of The European Society For Paediatric Endocrinology

OPKO Health, Inc. (NASDAQ:OPK) will present abstracts at the 55 th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE) to be held in Paris, France on September 10-12, 2016.

OPKO Health To Participate In Upcoming September Conferences

OPKO Health To Participate In Upcoming September Conferences

OPKO Health, Inc. (Nasdaq: OPK), today announced that senior management will participate in the 11 th Annual Wells Fargo Securities Healthcare Conference taking place September 7-8, 2016 in Boston and the 9 th Annual...

OPKO Health Completes Acquisition Of Transition Therapeutics

OPKO Health Completes Acquisition Of Transition Therapeutics

OPKO Health, Inc. (NASDAQ: OPK), announces that it has completed its previously announced acquisition of Transition Therapeutics, Inc.

'Mad Money' Lightning Round: I Am Committed to Opko Health

'Mad Money' Lightning Round: I Am Committed to Opko Health

Cramer says SolarCity is too hard for him and he's losing patience with Cigna.

Jim Cramer's 'Mad Money' Recap: These Are the Sectors to Buy Now

Jim Cramer's 'Mad Money' Recap: These Are the Sectors to Buy Now

With interest rate hikes this year a distinct possibility, the big money managers are springing into action, Cramer says. Here's what to buy.

Transition Therapeutics Shareholders Approve Acquisition By OPKO Health

Transition Therapeutics Shareholders Approve Acquisition By OPKO Health

OPKO Health, Inc. (Nasdaq: OPK), announces that at a Special Shareholder Meeting held on August 25, 2016 shareholders of Transition Therapeutics, Inc.

OPKO Health Responds To Law Firm Notice Of Investigation

OPKO Health Responds To Law Firm Notice Of Investigation

OPKO Health, Inc. (NYSE:OPK), is aware of a press release by Purcell Julie & Lefkowitz, LLP, a class action litigation firm, that it is investigating the Company for an alleged potential breach of fiduciary duty claim...

Opko Health (OPK) Stock Higher After Q2 Earnings Beat

Opko Health (OPK) Stock Higher After Q2 Earnings Beat

Opko Health (OPK) posted earnings and revenue that topped analysts' estimates for the 2016 second quarter following Monday's market close.

OPKO Health Reports Improved Financial And Operating Results

OPKO Health Reports Improved Financial And Operating Results

OPKO Health, Inc. (NYSE:OPK), reports financial and operating results for the three and six months ended June 30, 2016.

'Mad Money' Lightning Round: I'm Still With Opko Health

'Mad Money' Lightning Round: I'm Still With Opko Health

Cramer wants you to stick with Abbvie and says Cepheid is working.

Jim Cramer's 'Mad Money' Recap: Four Winning Themes, Four to Avoid

Jim Cramer's 'Mad Money' Recap: Four Winning Themes, Four to Avoid

Cramer has seen enough in this earnings season to come to some conclusions on what's working and what isn't.

OPKO To Announce Second Quarter Operating And Financial Results On August 8, 2016

OPKO To Announce Second Quarter Operating And Financial Results On August 8, 2016

OPKO Health, Inc. (NASDAQ:OPK) will release operating and financial results for the three and six months ended June 30, 2016, after the close of the U.

Opko Is a Buying Opportunity After FDA's Approval of Kidney Drug

Opko Is a Buying Opportunity After FDA's Approval of Kidney Drug

Banking on its Rayaldee treatment, this once-quiet pharmaceutical company has stepped up its investor profile with its first analyst day and a recent move to Nasdaq.

OPKO Health To Acquire Transition Therapeutics

OPKO Health To Acquire Transition Therapeutics

OPKO Health, Inc. (NASDAQ:OPK) and Transition Therapeutics Inc.

Weak On High Volume: Opko Health (OPK)

Weak On High Volume: Opko Health (OPK)

Trade-Ideas LLC identified Opko Health (OPK) as a weak on high relative volume candidate

Opko (OPK) Stock Gains as FDA Approves Rayaldee

Opko (OPK) Stock Gains as FDA Approves Rayaldee

Opko (OPK) stock is up this morning after the FDA approved its drug Rayaldee.

Morning Movers: BAC, MRO, NKE, OPK

Markets are projecting a positive open as Brexit-worries have abated.

'Mad Money' Lightning Round: Buy, Buy, Buy Medtronic

'Mad Money' Lightning Round: Buy, Buy, Buy Medtronic

Cramer sees Micron Technology getting back to $15 and urges caution on Holly Energy Partners.

Jim Cramer's 'Mad Money' Recap: Today's Rally Was Good but We Need More

Jim Cramer's 'Mad Money' Recap: Today's Rally Was Good but We Need More

The markets really need to see the financials, technology and healthcare sectors to move as they make up the bulk of our economy, says Jim Cramer.

OPKO Health To Host Analyst & Investor Day In New York City On June 15

OPKO Health To Host Analyst & Investor Day In New York City On June 15

OPKO Health, Inc. (NYSE:OPK) ("OPKO" or the "Company") announces that it will host an Analyst & Investor Day on Wednesday, June 15, 2016 beginning at 4:30 p.

Opko Health (OPK) Is Today's Strong On High Volume Stock

Opko Health (OPK) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Opko Health (OPK) as a strong on high relative volume candidate

OPKO Health Announces Move To NASDAQ Stock Market

OPKO Health Announces Move To NASDAQ Stock Market

OPKO Health, Inc. (NYSE:OPK) ("OPKO" or the "Company") announces that it will move its stock exchange listing to The NASDAQ Stock Market from The New York Stock Exchange (the "NYSE").

OPKO To Discuss Draft Coverage Determinations For 4Kscore® Test At 2016 Jefferies Healthcare Conference

OPKO To Discuss Draft Coverage Determinations For 4Kscore® Test At 2016 Jefferies Healthcare Conference

OPKO Health, Inc. (NYSE: OPK) today announced that senior management will discuss recent draft local coverage determinations by certain Medicare Administrative Contractors for OPKO's 4Kscore® test at the Jefferies...